Financing, Equity Capital Markets

Leap Therapeutics

06/20
|
$40.0 Million
Piper Sandler served as bookrunner for Leap Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma